Park Medi World cash falls Rs 163.67 crore in first half

Park Medi World Limited reported a Rs 163.67 crore decrease in cash and cash equivalents in the half year ended September 30, 2026, to Rs 76.22 crore, as Rs 200.35 crore of operating cash use and Rs 157.25 crore of investing outflow exceeded a Rs 193.93 crore financing inflow.

Why did Park Medi World’s cash balance fall in the first half?

Park Medi World’s cash balance fell because operating and investing outflows together exceeded the financing inflow during the half year ended September 30, 2026. Cash and cash equivalents decreased from Rs 236.85 crore at the beginning of the year to Rs 76.22 crore, after including Rs 3.04 crore of cash and cash equivalents from a business combination.

The latest result contrasts with the half year ended September 30, 2025, when cash and cash equivalents increased by Rs 49.61 crore to Rs 53.40 crore. In the 2026 period, net operating cash use of Rs 200.35 crore and net investing cash use of Rs 157.25 crore totalled Rs 357.60 crore, compared with a Rs 193.93 crore financing inflow.

What caused Park Medi World’s operating cash outflow?

Park Medi World used Rs 200.35 crore in operating activities in the half year ended September 30, 2026, compared with Rs 132.30 crore used a year earlier. Operating profit before working-capital changes rose to Rs 232.48 crore from Rs 223.61 crore, but a Rs 392.84 crore working-capital outflow and Rs 40.46 crore of income-tax payments led to cash use.

Trade receivables increased by Rs 171.70 crore, the largest individual working-capital cash outflow in the latest half year, versus an increase of Rs 158.74 crore in the prior-year period. Other financial assets increased by Rs 60.25 crore, compared with Rs 144.97 crore a year earlier, while trade payables decreased by Rs 64.15 crore and inventory increased by Rs 0.97 crore.

Park Medi World reported profit before tax of Rs 181.50 crore for the half year, up from Rs 173.24 crore a year earlier. The operating calculation included non-cash depreciation and amortisation of Rs 39.70 crore, finance costs of Rs 23.89 crore and a Rs 2.85 crore impairment of trade receivables, but these adjustments did not offset the cash absorbed by working capital.

How much did Park Medi World spend on acquisitions and capital assets?

Park Medi World used Rs 157.25 crore in investing activities in the latest first half, reversing a Rs 105.35 crore investing inflow in the comparable 2025 period. The largest outflow was Rs 113.44 crore invested in subsidiaries acquired during the period, followed by Rs 59.89 crore for property, plant and equipment, intangible assets and capital work-in-progress.

The acquisition spending coincided with Park Medi World acquiring an 80% holding in V3 Health Care Private Limited on July 31, 2026. The subsidiary operates The Medicity Hospital in Rudrapur, Uttarakhand, which has 330 beds; the filing puts the overall acquisition cost at about Rs 162.84 crore and says the remaining 20% is due to be acquired by April 30, 2030.

Loans given used Rs 16.46 crore and investments increased by Rs 0.51 crore. These outflows were partly offset by a Rs 19.02 crore decrease in bank deposits, Rs 13.27 crore of interest income and Rs 0.75 crore of rental income, leaving the overall investing cash outflow at Rs 157.25 crore.

The balance sheet also recorded changes associated with investment and expansion activity. Property, plant and equipment rose to Rs 1,098.72 crore at September 30, 2026 from Rs 787.83 crore at March 31, 2026, while goodwill increased to Rs 424.72 crore from Rs 389.89 crore; capital work-in-progress declined to Rs 22.99 crore from Rs 123.14 crore.

How did Park Medi World finance its cash requirements?

Park Medi World generated Rs 193.93 crore of net financing cash inflow in the half year ended September 30, 2026, compared with a Rs 22.66 crore outflow a year earlier. Net proceeds from borrowings were Rs 212.77 crore, partly offset by Rs 1.54 crore of lease-liability payments and Rs 17.29 crore of finance costs.

Current borrowings were Rs 27.92 crore at September 30, 2026, down from Rs 208.04 crore at March 31, 2026, while non-current borrowings increased to Rs 179.15 crore from Rs 18.96 crore. The figures show a shift in the reported borrowing balance from current to non-current liabilities during the six-month period.

Park Medi World said its initial public offering proceeds were fully used by September 30, 2026 after allocations were revised through a September 3, 2026 postal-ballot resolution. The disclosed uses included Rs 380 crore for repayment or prepayment of borrowings, Rs 245.32 crore for unidentified inorganic acquisitions and general corporate purposes, and Rs 64.83 crore for capital expenditure relating to The Medicity Hospital, Rudrapur.

What commitments could affect Park Medi World’s future cash needs?

Park Medi World incorporated Park Medicity Prayagraj Private Limited on September 8, 2026 to develop and operate a 550-bed multi-super-speciality hospital in Prayagraj, Uttar Pradesh. The filing says the project was awarded by the Prayagraj Municipal Corporation under a public-private partnership model, but it does not disclose a project cost or financing plan.

A wholly owned subsidiary entered an operation and management agreement for a 300-bed multi-super-speciality hospital in Kanpur for 28 years from April 1, 2027. Separately, Park Medi World’s board approved on August 3, 2026 a proposal to acquire 100% of Mehar Mediserve LLP by December 3, 2026; its Mehar Hospital in Zirakpur, Punjab, has capacity of more than 150 beds.

The filing also states that the Income Tax Department conducted searches or surveys at certain premises related to Park Medi World, subsidiaries and company officials from October 12 to October 17, 2026. Park Medi World stated that the events had no impact on operations, commitments or expansion plans, and did not disclose a financial amount connected with them.

Conclusion

Park Medi World’s Rs 163.67 crore first-half cash decline resulted from operating cash use of Rs 200.35 crore and investing cash use of Rs 157.25 crore, including subsidiary acquisitions and capital spending. Net financing inflow of Rs 193.93 crore, principally from Rs 212.77 crore of net borrowing proceeds, offset only part of those combined outflows.

The next disclosed milestones are the proposed Mehar Mediserve LLP acquisition by December 3, 2026, the 28-year Kanpur management arrangement beginning April 1, 2027, and the purchase of V3 Health Care’s remaining 20% by April 30, 2030. Future results can show the cash effects of these commitments, the 550-bed Prayagraj project and working-capital movements after September 2026.